Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07675109 · ClinicalTrials.gov registry record · NA
Optimizing Extended-Duration (XD-) TOMAC Therapy for Restless Legs Syndrome (RLS)
A NA study, sponsored by Noctrix Health.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT07675109 is a NA study that is actively recruiting participants, run by Noctrix Health. The registered enrollment target is 20 participants.
The verdict
NCT07675109, a NA study, is actively recruiting participants, sponsored by Noctrix Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study assesses the tolerability, safety, and impact of an investigational medical device on restless legs syndrome symptoms. The IRB has established that the investigational device is non-significant risk.
Interventions
- DEVICE Investigational Extended Duration (XD-) TOMAC Therapy
- DEVICE Tonic Motor Activation (TOMAC) Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-06-08 |
| Est. Completion | 2027-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07675109
The ClinicalTrials.gov registry entry for NCT07675109 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Noctrix Health, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Investigational Extended Duration (XD-) TOMAC Therapy is the first listed.
NCT07675109 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07675109 about?
NCT07675109 is a clinical study titled "Optimizing Extended-Duration (XD-) TOMAC Therapy for Restless Legs Syndrome (RLS)". This study assesses the tolerability, safety, and impact of an investigational medical device on restless legs syndrome symptoms. The IRB has established that the investigational device is non-significant risk.
What is the current status of trial NCT07675109?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-06-08. Estimated completion is 2027-06.
What interventions are being tested in trial NCT07675109?
The interventions under investigation include: Investigational Extended Duration (XD-) TOMAC Therapy (DEVICE), Tonic Motor Activation (TOMAC) Therapy (DEVICE).
Who is sponsoring clinical trial NCT07675109?
This trial is sponsored by Noctrix Health, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.